People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Thyme Care, Inc. | — | Healthtech | Series C | $214.3M | $668.4M | 2025 |
Jesse Waldron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jesse Waldron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Green | 1 | 8 |
| Vineeta Agarwala | 1 | 8 |
| Brenton Fargnoli | 1 | 7 |
| Vivek Garipalli | 1 | 5 |
| David Whelan | 1 | 5 |
| Puneet Singh | 1 | 4 |
| Vijay Patel | 1 | 3 |
| Michael Markowicz | 1 | 1 |
| Brian Belsky | 1 | 1 |
| Elizabeth Canis | 1 | 1 |
| Robin Shah | 1 | 1 |
| Bradford Diephuis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.